Evidence map›Paper›PMID 25728839›Full record

ArticleCerebellum (London, England)2015

Cerebellar Hypoplasia and Dysmorphia in Neurofibromatosis Type 1.

Sandra P Toelle, Andrea Poretti, Peter Weber, Tatjana Seute, Jacoline E C Bromberg, Ianina Scheer, Eugen Boltshauser

Abstract read
PubMed Publisher
In one paragraph

Article in Cerebellum (London, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Sandra P ToelleDepartment of Pediatric Neurology, University Children's Hospital, Steinwiesstrasse 75, 8032, Zurich, Switzerland.
Andrea PorettiDepartment of Pediatric Neurology, University Children's Hospital, Steinwiesstrasse 75, 8032, Zurich, Switzerland.
Peter WeberDepartment of Pediatric Neurology and Developmental Medicine, University Children's Hospital, Basel, Switzerland.
Tatjana SeuteDepartment of Neurology and Neurosurgery, University Medical Center, Utrecht, The Netherlands.
Jacoline E C BrombergDepartment of Neuro-Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Ianina ScheerDepartment of Diagnostic Imaging, University Children's Hospital, Zurich, Switzerland.
Eugen BoltshauserDepartment of Pediatric Neurology, University Children's Hospital, Steinwiesstrasse 75, 8032, Zurich, Switzerland. Eugen.Boltshauser@bluewin.ch.
University Children's Hospital Zurich · CHErasmus MC Cancer Institute · NLJohns Hopkins University · USUniversity Children’s Hospital Basel · CHUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Unidentified bright objects (UBO) and tumors are well-known cerebellar abnormalities in neurofibromatosis type 1 (NF1). Literature reports on malformative cerebellar anomalies in neurofibromatosis type 1 (NF1), however, are scant. We retrospectively studied the clinical and neuroimaging findings of 5 patients with NF1 (4 females, age 6 to 29 years at last follow-up) and cerebellar anomalies. Cerebellar symptoms on neurological examination were mild or even not evident whereas learning disabilities were more or less pronounced in four patients. Two patients had cerebellar hypoplasia (diffusely enlarged cerebellar interfoliar spaces) and three cerebellar dysmorphias involving mainly one cerebellar hemisphere. In NF1, malformative cerebellar anomalies are rare (estimated prevalence of about 1%), but most likely underestimated and easily overlooked, because physicians tend to focus on more prevalent, obvious, and well-known findings such as optic pathway gliomas, other tumors, and UBO. This kind of cerebellar anomaly in NF1 has most likely a malformative origin, but the exact pathogenesis is unknown. The individual clinical significance is difficult to determine. We suggest that cerebellar anomalies should be systematically evaluated in neuroimaging studies of NF1 patients.

Indexed as

AdolescentAdultBrainCerebellumChildDevelopmental DisabilitiesFemaleFollow-Up StudiesHumansMagnetic Resonance ImagingMaleNervous System MalformationsNeurofibromatosis 1Retrospective StudiesYoung AdultCerebellar dysmorphiaCerebellar hypoplasiaCerebellumNeurofibromatosis type 1Neuroimaging

Identifiers

PMID25728839
OpenAlexW2125801006

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.